ADC Therapeutics SA (ADCT)
CIK 1771910 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ADC Therapeutics SA.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G | 0001104659-26-097255 |
| Aug 13, 2026 | 10-Q | 0001628280-26-056711 |
| Aug 13, 2026 | 8-K | 0000950103-26-012287 |
| Aug 13, 2026 | S-8 | 0000950103-26-012337 |
| Jul 27, 2026 | SCHEDULE 13G | 0002012383-26-002147 |
| Jul 2, 2026 | 8-K | 0000950103-26-010195 |
| Jul 2, 2026 | 4 | 0001628280-26-047033 |
| Jul 2, 2026 | 4 | 0001628280-26-047034 |
| Jul 2, 2026 | 4 | 0001628280-26-047036 |
| Jul 2, 2026 | 4 | 0001628280-26-047031 |
| Jun 24, 2026 | 8-K | 0000950103-26-009416 |
| Jun 3, 2026 | 8-K | 0000950103-26-008465 |
| Jun 3, 2026 | 4 | 0001628280-26-040488 |
| Jun 3, 2026 | 4 | 0001628280-26-040493 |
| Jun 3, 2026 | 4 | 0001628280-26-040490 |
| Jun 3, 2026 | 4 | 0001628280-26-040487 |
| Jun 3, 2026 | 4 | 0001628280-26-040491 |
| Jun 3, 2026 | 4 | 0001628280-26-040489 |
| Jun 3, 2026 | 4 | 0001628280-26-040492 |
| Jun 2, 2026 | 8-K | 0000950103-26-008321 |
| May 4, 2026 | 8-K | 0001628280-26-029524 |
| May 4, 2026 | 10-Q | 0001628280-26-029819 |
| Apr 24, 2026 | SCHEDULE 13G/A | 0001104659-26-048804 |
| Apr 20, 2026 | DEF 14A | 0001140361-26-015491 |
| Apr 20, 2026 | DEFA14A | 0000950103-26-005918 |